Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 146,534 | 164,659 | 180,510 | 96,942 | 176,857 |
| Marketable Securities | 50,040 | 48,057 | 28,911 | 123,763 | 39,323 |
| Receivables | 57,950 | 59,288 | 61,466 | 53,976 | 50,672 |
| Inventories | 85,998 | 78,905 | 75,863 | 75,333 | 69,295 |
| Income taxes - deferred | 13,860 | 14,544 | 13,674 | 13,775 | 15,329 |
| Other current assets | 6,038 | 5,788 | 6,454 | 6,800 | 5,882 |
| TOTAL | $360,420 | $371,241 | $366,878 | $370,589 | $357,358 |
| Non-Current Assets | |||||
| PPE Net | 58,329 | 56,509 | 48,393 | 45,224 | 51,832 |
| Investments And Advances | 18,386 | 21,148 | 33,787 | 35,082 | 25,110 |
| Intangibles | 5,606 | 0 | 0 | 61,766 | 4,439 |
| Other Non-Current Assets | 69,663 | 74,303 | 74,027 | 9,214 | 58,480 |
| TOTAL | $151,984 | $151,960 | $156,207 | $151,286 | $139,861 |
| Total Assets | $512,404 | $523,201 | $523,085 | $521,875 | $497,219 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,786 | 19,467 | 14,848 | 19,160 | 12,600 |
| Accrued Expenses | 50,224 | 46,118 | 48,218 | 49,075 | 66,597 |
| Other current liabilities | N/A | N/A | N/A | 2,250 | N/A |
| TOTAL | $93,977 | $89,049 | $86,600 | $100,345 | $87,957 |
| Non-Current Liabilities | |||||
| Long Term Debt | 500 | 500 | 500 | N/A | N/A |
| Deferred Revenues | 7,511 | 8,167 | 8,252 | 8,275 | 8,271 |
| Other Non-Current Liabilities | 1,464 | 2,693 | 2,912 | 2,230 | 240 |
| TOTAL | $9,698 | $10,095 | $9,540 | $8,238 | $6,443 |
| Total Liabilities | $103,675 | $99,144 | $96,140 | $108,583 | $94,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 134,604 | 137,025 | 138,912 | 138,813 | 139,419 |
| Common Shares | 4,516 | 4,513 | 4,489 | 4,439 | 4,410 |
| Retained earnings | 301,747 | 282,051 | 258,141 | 240,350 | 227,985 |
| Other shareholders' equity | 6,957 | 6,867 | 7,311 | 4,254 | 1,652 |
| TOTAL | $408,729 | $424,057 | $426,945 | $413,292 | $402,819 |
| Total Liabilities And Equity | $512,404 | $523,201 | $523,085 | $521,875 | $497,219 |